跳至主要内容
临床试验/NCT05364827
NCT05364827招募中不适用

Computed Tomography Coronary Angiography (CTCA) Prior to Chronic Total Occlusion (CTO) Percutaneous Coronary Intervention (PCI) - a Feasibility Study

Sandwell & West Birmingham Hospitals NHS Trust2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2022年6月30日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
20
试验地点
2
主要终点
Primary Outcome

研究概览

简要总结

A Chronic Total Occlusion or CTO of a coronary artery is a an artery that has been blocked for >/= 3 months. More than a decade ago, patients with such coronary artery blockage would have been sent for Coronary Artery Bypass Graft (CABG) surgery. Newer tools and techniques have facilitated the opening (angioplasty or percutaneous coronary intervention (PCI)) of such occluded arteries- however success is not 100% unlike in simple coronary blockages.

Computed Tomography Coronary Angiography (CTCA) identifies the artery path and characteristics of the CTO including calcification - the latter many times is the reason for failure to cross the CTO.

The investigators aim to conduct a feasibility study to assess the effectiveness of CTCA prior to CTO PCI by randomizing suitable CTO patients to CTCA or direct CTO PCI.

20 patients will be randomized 1:1 using the sealed envelope technique and compared for:

Primary endpoint:

CTO PCI success rate in CTCA arm versus no CTCA arm

Secondary endpoints:

i. Angina by the Seattle Angina Questionnaire (SAQ) at 6 months (range 0-100, lower score worse, higher scores better, based on 5 characteristics - severity, frequency, treatment satisfaction and quality of life scores).

ii. Compare the number of patients who required a second CTO PCI procedure in the CTCA arm versus no CTCA arm iii. Procedural differences between the intervention CTCA arm versus no CTCA arm including: Health Economics: Cost saved per patient due to improved success and reduction in readmission or further procedure CTO PCI efficiency: Wire crossing time, Procedure time CTO PCI safety outcomes: Procedural complications (Ellis perforation, tamponade, acute kidney injury/contrast induced nephropathy, access site bleeding, donor vessel injury), Radiation: CTCA dose, CTO PCI dose, and combined CTCA and CTO PCI dose. Contrast: CTCA volume, CTO PCI volume, and combined CTCA and CTO PCI volume Change in CTO PCI strategy hierarchy as a result of the CTCA review

Patients will have a telephonic follow up at 6 months to assess angina ( by the Seattle Angina Questionnaire)

详细描述

Computed Tomography Coronary Angiography (CTCA) prior to Chronic Total Occlusion (CTO) Percutaneous Coronary Intervention (PCI) - a feasibility study

Summary of Trial design:

Randomised, prospective, single centre feasibility study of CTCA prior to CTO PCI

Site and Chief Investigator:

Sandwell and West Birmingham NHS Trust, Birmingham, United Kingdom Vinoda Sharma

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥18 years
  • CTO with J-CTO score≥2
  • Appropriate indication for CTO PCI
  • Adequate CTCA images for analysis

排除标准

  • <18 years of age
  • CTO with J-CTO score<2
  • Inadequate/degraded CTCA images
  • Pregnant/lactating women
  • Patients with severe contrast allergy
  • Patients unable to provide written informed consent

结局指标

主要结局

Primary Outcome

时间窗: 24 hours = Day 0 of the index CTO PCI procedure

CTO PCI success rate in CTCA arm versus no CTCA arm

次要结局

  • i. Angina(6 months)
  • ii. More than one CTO PCI procedure required(24 hours = Day 0 of the index CTO PCI procedure)
  • iv. Procedural differences between the intervention CTCA arm versus no CTCA arm-CTO PCI wire crossing time(24 hours = Day 0 of the index CTO PCI procedure)
  • iii. Procedural differences between the intervention CTCA arm versus no CTCA arm-health economics(One year = At the end of the study)
  • v. Procedural differences between the intervention CTCA arm versus no CTCA arm-CTO PCI total procedure time(24 hours = Day 0 of the index CTO PCI procedure)
  • vi. CTO PCI safety outcomes: Procedural complications (Ellis perforation, tamponade, acute kidney injury/contrast induced nephropathy, access site bleeding, donor vessel injury)(24 hours = Day 0 of the index CTO PCI procedure except acute kidney injury which will be based on blood tests 48 hours after completion of the procedure)
  • vii. CTO PCI safety outcomes: Radiation: CTCA dose, CTO PCI dose, and combined CTCA and CTO PCI dose(24 hours = Day 0 of the index CTO PCI procedure)
  • viii. CTO PCI safety outcomes: Contrast: CTCA volume, CTO PCI volume, and combined CTCA and CTO PCI volume(24 hours = Day 0 of the index CTO PCI procedure)
  • ix. Change in CTO PCI strategy hierarchy as a result of the CTCA review : Initial procedure strategy in planning versus actual initial and final procedure strategy(24 hours = Day 0 of the index CTO PCI procedure)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Vinoda Sharma

Consultant Interventional Cardiologist

Sandwell & West Birmingham Hospitals NHS Trust

研究点 (2)

Loading locations...

相似试验